GlassScriptPhysician profile
Gregory Mulford
NPI 1083680771
$1,307.67
in general payments reported to CMS, 2019-2025
20 companies · $72.38 in 2025
The $72.38 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $108 · 2021: $164 · 2022: $127 · 2023: $207 · 2024: $353 · 2025: $72.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $632.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $632.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $285.87 | 2019-2025 | Euflexxa |
| Ipsen Biopharmaceuticals, INC | $269.04 | 2019-2025 | Dysport |
| Abbvie INC. | $143.36 | 2022-2025 | |
| Allergan, INC. | $96.13 | 2019-2021 | |
| Averitas Pharma INC. | $72.37 | 2023-2024 | Qutenza |
| Pfizer INC. | $64.44 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $50.60 | 2021-2022 | |
| Spr Therapeutics, INC | $41.85 | 2019-2024 | Sprint Pns System |
| Medtronic USA, INC. | $35.59 | 2019 | |
| Redhill Biopharma INC. | $28.56 | 2020-2021 | |
| Depuy Synthes Sales INC. | $28.03 | 2024 | Monovisc |
| Medtronic, INC. | $27.56 | 2024 | Intellis Adaptivestim |
| Horizon Therapeutics Plc | $27.02 | 2019 | |
| Boston Scientific Corporation | $25.75 | 2024 | |
| Ibsa Pharma INC. | $24.61 | 2023 | Tirosint, Licart |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $23.98 | 2023 | Eterna |
| Stryker Corporation | $20.23 | 2024 | Motionsense Digital Goniometer |
| Merz Pharmaceuticals, LLC | $15.79 | 2023 | Xeomin |
| Daiichi Sankyo INC. | $13.67 | 2019 | |
| Fidia Pharma USA INC. | $13.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Mulford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.